½ÃÀ庸°í¼­
»óǰÄÚµå
1741350

¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ŰƮ À¯Çüº°, ±â¼úº°, °Ë»ç Ç׸ñº°, ¹Ì»ý¹°º°, ¸ñÀûº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°

Biotechnology Reagents and Kits Market, By Kit Type, By Technology, By Tested parameters, By Micro-organisms, By Purpose, By End Use, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀåÀº 2025³â 8¾ï 2,800¸¸ ´Þ·¯, 2032³â¿¡´Â 17¾ï 7,400¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 11.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÐ¼® ¹üÀ§ ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 8¾ï 2,800¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) 11.50% ¿¹Ãø ±Ý¾×(2032³â) 17¾ï 7,400¸¸ ´Þ·¯

»ý¸í°øÇÐ¿ë ½Ã¾àÀº °Ë»ç °ªÀ» Á¦°øÇϱâ À§ÇØ ´Ù¸¥ ¹°ÁúÀ» °ËÃâÇϰųª ÇÕ¼ºÇÏ´Â µ¥ »ç¿ëµÇ´Â ¹°Áú ¶Ç´Â È­ÇÕ¹°ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¾àÀº ¿¬±¸, Áø´Ü, »ý¹°°úÇÐ, ±³À° ºÐ¾ß¿¡¼­ »ç¿ëµË´Ï´Ù. »ý¸í°øÇÐ¿ë ½Ã¾à ¹× Å°Æ®´Â ½ÇÇè ¼öÇà, »ý¹°ÇÐÀû »ùÇà ºÐ¼®, ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÇöÀçÀÇ RNA ¶óÀ̺귯¸® Áغñ Á¢±Ù¹ýÀº ½Ã°£ÀÌ ¿À·¡ °É¸®°í, º¹ÀâÇϸç, ¿À·ù°¡ ¹ß»ýÇϱ⠽±°í, ¿©·¯ ´Ü°èÀÇ °øÁ¤¿¡¼­ °¢ ´Ü°è¸¶´Ù »ùÇà ¼Õ½ÇÀÌ ¹ß»ýÇϱ⠶§¹®¿¡ ÁÖ¿ä ½ÃÀå ±â¾÷µéÀÌ ½ÅÁ¦Ç° Ãâ½Ã¸¦ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è »ý¸í°øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 6¿ù »ý¸í°úÇÐ ¿¬±¸ ¹× ÀÓ»ó Áø´Ü Á¦Ç°ÀÇ ¼¼°è ¸®´õÀÎ Bio-Rad Laboratories, Inc.´Â SEQuoia Express Stranded RNA Library Prep KitÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Å°Æ®´Â ¹ÙÀÌ¿ÀÁ¦¾à ¹× ¿¬±¸ °úÇÐÀڵ鿡°Ô Á¾ÇÕÀûÀÎ Àü»çü ÇÁ·ÎÆÄÀϸµÀ» À§ÇÑ È¿À²ÀûÀÎ RNA-Seq ¿öÅ©Ç÷ο츦 Áö¿øÇÏ´Â °ß°íÇÑ ¶óÀ̺귯¸®¸¦ ±¸ÃàÇÒ ¼ö ÀÖ´Â »ç¿ëÇϱ⠽¬¿î ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­ÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ »ý¸í°øÇÐ¿ë ½Ã¾à ¹× Å°Æ® ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, °¢ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ, ½ÃÀå ÃËÁø ¹× ¾ïÁ¦¿äÀÎ ¹× ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ¾÷üµéÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è »ý¸í°øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, Á¦ÈÞ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è »ý¸í°øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è »ý¸í°øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • ºÐ¼® ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å ¹× ½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ±â¾÷ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ½ÅÇü Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ŰƮ À¯Çüº°(2020-2032³â)

  • Á¤È­ ŰƮ
  • ÁõÆø ŰƮ
  • °¨Áö ŰƮ
  • °Ý¸® ŰƮ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ±â¼úº°(2020-2032³â)

  • LAMP ±â¼ú
  • PCR
  • ¼¼Æ÷¹è¾ç
  • ½ÃÄö½Ì
  • Å©·Î¸¶Åä±×·¡ÇÇ
  • Àü±â¿µµ¿
  • À¯¼¼Æ÷ºÐ¼®±â
  • ±âŸ ±â¼ú

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : °Ë»ç Ç׸ñº°(2020-2032³â)

  • DNA
  • RNA
  • È¿¼Ò
  • ´Ü¹éÁú
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ¹Ì»ý¹°º°(2020-2032³â)

  • ¼¼±Õ
  • ¹ÙÀÌ·¯½º
  • ±Õ·ù
  • ±â»ýÃæ

Á¦9Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ¸ñÀûº°(2020-2032³â)

  • ÇöÀå(¿Â»çÀÌÆ®)
  • °Ë»ç½Ç

Á¦10Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°(2020-2032³â)

  • ÀÇ·á
  • ½Äǰ ¹× ³ó¾÷
  • õ¿¬ÀÚ¿ø ¹× ȯ°æ
  • »ê¾÷ ó¸®
  • ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º

Á¦11Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿ë ½Ã¾à ¹× ŰƮ ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • New England Biolabs
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • Takara Bio Inc.

Á¦13Àå ¼½¼Ç

  • ºÐ¼® ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 25.06.18

Biotechnology Reagents and Kits Market is estimated to be valued at USD 828.0 Mn in 2025 and is expected to reach USD 1,774.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 828.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.50% 2032 Value Projection: USD 1,774.0 Mn

Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education. Biotechnology reagents & kits are essential tools for conducting experiments, analyzing biological samples, and creating biopharmaceuticals.

Market Dynamics:

Current RNA library preparation approaches are time-consuming, complex, and potentially error-prone, with sample loss observed at each stage in processes with multiple steps thus the key market players are engaged in launching new products and this is expected to propel growth of the global biotechnology reagents and kits market over the forecast period. For instance, in June 2022, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling

Key features of the study:

  • This report provides in-depth analysis of the global biotechnology reagents and kits market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global biotechnology reagents and kits market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., QIAGEN, New England Biolabs, Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Takara Bio Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global biotechnology reagents and kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biotechnology reagents and kits market.

Detailed Segmentation:

  • Global Biotechnology Reagents and Kits Market, By Kit Type:
    • Purification Kits
    • Amplification Kits
    • Detection Kits
    • Isolation Kits
    • Others
  • Global Biotechnology Reagents and Kits Market, By Technology:
    • LAMP Technology
    • PCR
    • Cell Culture
    • Sequencing
    • Chromatography
    • Electrophoresis
    • Flow Cytometry
    • Other Technologies
  • Global Biotechnology Reagents and Kits Market, By Tested Parameters:
    • DNA
    • RNA
    • Enzymes
    • Proteins
    • Others
  • Global Biotechnology Reagents and Kits Market, By Micro-organisms:
    • Bacteria
    • Virus
    • Fungi
    • Parasites
  • Global Biotechnology Reagents and Kits Market, By Purpose:
    • On-site
    • Laboratory
  • Global Biotechnology Reagents and Kits Market, By End Use:
    • Healthcare
    • Food & Agriculture
    • Natural Resources & Environment
    • Industrial Processing
    • Bioinformatics
  • Global Biotechnology Reagents and Kits Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific, Inc.
    • QIAGEN
    • New England Biolabs
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • F.Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Promega Corporation
    • Takara Bio Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Kit Type
    • Market Snapshot, By Technology
    • Market Snapshot, By Tested Parameters
    • Market Snapshot, By Micro-organisms
    • Market Snapshot, By Purpose
    • Market Snapshot, By End Use
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in geriatric population
    • Increasing prevalence of hypertension
    • Technological advancements
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biotechnology Reagents and Kits Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biotechnology Reagents and Kits Market, By Kit Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Purification Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Amplification Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Detection Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Isolation Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Biotechnology Reagents and Kits Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • LAMP Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cell Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Chromatography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Electrophoresis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Biotechnology Reagents and Kits Market, By Tested Parameters, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Biotechnology Reagents and Kits Market, By Micro-organisms, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Bacteria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Fungi
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Parasites
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Biotechnology Reagents and Kits Market, By Purpose, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • On-site
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Laboratory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

10. Global Biotechnology Reagents and Kits Market, By End Use, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Healthcare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Food & Agriculture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Natural Resources & Environment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Industrial Processing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Bioinformatics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

11. Global Biotechnology Reagents and Kits Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Kit Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tested Parameters, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Micro-organisms, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Purpose, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020-2032,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Kit Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tested Parameters, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Micro-organisms, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Purpose, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020-2032,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Kit Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tested Parameters, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Micro-organisms, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Purpose, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020-2032,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Kit Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tested Parameters, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Micro-organisms, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Purpose, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020-2032,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Kit Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Tested Parameters, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Micro-organisms, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Purpose, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020-2032,(US$ Mn)

12. Competitive Landscape

  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takara Bio Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

13. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦